Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04076917 · ClinicalTrials.gov registry record
Assessment of the Utility of BIOMONITOR to Identify Atrial Fibrillation (AF) in Ablation Candidates Using Precise AF Detection
A clinical trial, sponsored by Biotronik.
- Terminated
- Registry status
- 84
- Enrollment target
NCT04076917 is a clinical trial that was terminated before completion, run by Biotronik. The registered enrollment target is 84 participants.
The verdict
NCT04076917 was terminated before completion, sponsored by Biotronik.
- TERMINATED
- Registry status
- 84 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the diagnostic utility of BIOTRONIK's subcutaneous cardiac rhythm monitor for the detection of AF prior to an ablation procedure.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2019-09-25 |
| Est. Completion | 2021-02-24 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04076917
The ClinicalTrials.gov registry entry for NCT04076917 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 84 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Biotronik, which has 30 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04076917 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04076917 about?
NCT04076917 is a clinical study titled "Assessment of the Utility of BIOMONITOR to Identify Atrial Fibrillation (AF) in Ablation Candidates Using Precise AF Detection". The purpose of this study is to evaluate the diagnostic utility of BIOTRONIK's subcutaneous cardiac rhythm monitor for the detection of AF prior to an ablation procedure.
What is the current status of trial NCT04076917?
This trial is currently terminated. The enrollment target is 84 participants. The study started on 2019-09-25. Estimated completion is 2021-02-24.
Who is sponsoring clinical trial NCT04076917?
This trial is sponsored by Biotronik, which has 30 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.